open access

Vol 1, No 1 (2013)
Original article
Published online: 2013-07-11
Get Citation

Fluorescence spectroscopy in a study of anticancer drugs: 7-tert-butyldimethylsilyl-camptothecin and 7-tert-butyldimethylsilyl-10-[4- (1-piperidino)-1-piperidino]-carbonyloxycamptothecin

Natalia Sørbotten, Stefan Kruszewski
Folia Medica Copernicana 2013;1(1):23-30.

open access

Vol 1, No 1 (2013)
ORIGINAL ARTICLES
Published online: 2013-07-11

Abstract

Background. Camptothecin (CPT), an alkaloid isolated from the Chinese tree Camptotheca acuminata,exhibits very high anticancer activity. CPT is a fluorescent compound and this is a very useful property. Using methods of fluorescence spectroscopy, one can determine or predict the biophysical propertiesof this promising compound. The cellular target of CPT is topoisomerase I. CPT interacts only with thosecells which are in the S-phase. CPT molecules bind to topoisomerase I – DNA complex and prevent thereplication process. This means that CPT is toxic to those cells that are undergoing DNA synthesis. Cancerouscells are rapidly replicating and they spend more time in the S-phase in relation to healthy tissues,and therefore they are killed with much higher efficiency than the healthy host tissues. Such selectivity ofcytotoxicity is a promising property of CPT. Due to the S-phase specificity of CPT, a continuous exposureto this drug must be maintained in order to achieve optimum therapeutic efficacy.

Materials and methods. We used fluorescence anisotropy measurements to determine the properties ofbinding to membranes and proteins of two anticancer agents: 7-tert-butyldimethylsilyl-camptothecin and7-tert-butyldimethylsilyl- 10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin. The samples of CPT,1Si-CPT and 2Si-CPT were obtained from the laboratory of biotechnology, College of Pharmacy, Universityof Kentucky, Lexington, USA. 2 mM stock solutions of CPT, 1Si-CPT and 2Si-CPT were prepared in DMSO.As model membranes, small unilamelar liposomes formed by DMPC and DMPG lipids were used.

Results. Fluorescence anisotropy measurements prove that this new camptothecin analogue exhibitsdesirable properties: high affinity of lactone form to membranes and low affinity of carboxylate form toHSA. Such properties should ensure high stability of this drug in physiological fluids, including blood.The second considered compound, 7-tert-butyldimethylsilyl- camptothecin, exhibits very high affinity of itslactone form to membranes, but its carboxylate form exhibits also high affinity to HSA. The latter propertyexcludes this compound as a candidate to be a good anticancer drug.

Conclusions. Fluorescence anisotropy measurements show that the lactone forms of 1Si-CPT and 2Si-CPTexhibit a high affinity to membranes but only the carboxylate form of 2Si-CPT behaves in a desirable way inHSA solution i.e. it exhibits a low affinity to this protein. This means that 2Si-CPT could be an excellent candidatefor further in vivo pharmacological studies, and most probably for clinical trials in cancer chemotherapy.

Abstract

Background. Camptothecin (CPT), an alkaloid isolated from the Chinese tree Camptotheca acuminata,exhibits very high anticancer activity. CPT is a fluorescent compound and this is a very useful property. Using methods of fluorescence spectroscopy, one can determine or predict the biophysical propertiesof this promising compound. The cellular target of CPT is topoisomerase I. CPT interacts only with thosecells which are in the S-phase. CPT molecules bind to topoisomerase I – DNA complex and prevent thereplication process. This means that CPT is toxic to those cells that are undergoing DNA synthesis. Cancerouscells are rapidly replicating and they spend more time in the S-phase in relation to healthy tissues,and therefore they are killed with much higher efficiency than the healthy host tissues. Such selectivity ofcytotoxicity is a promising property of CPT. Due to the S-phase specificity of CPT, a continuous exposureto this drug must be maintained in order to achieve optimum therapeutic efficacy.

Materials and methods. We used fluorescence anisotropy measurements to determine the properties ofbinding to membranes and proteins of two anticancer agents: 7-tert-butyldimethylsilyl-camptothecin and7-tert-butyldimethylsilyl- 10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin. The samples of CPT,1Si-CPT and 2Si-CPT were obtained from the laboratory of biotechnology, College of Pharmacy, Universityof Kentucky, Lexington, USA. 2 mM stock solutions of CPT, 1Si-CPT and 2Si-CPT were prepared in DMSO.As model membranes, small unilamelar liposomes formed by DMPC and DMPG lipids were used.

Results. Fluorescence anisotropy measurements prove that this new camptothecin analogue exhibitsdesirable properties: high affinity of lactone form to membranes and low affinity of carboxylate form toHSA. Such properties should ensure high stability of this drug in physiological fluids, including blood.The second considered compound, 7-tert-butyldimethylsilyl- camptothecin, exhibits very high affinity of itslactone form to membranes, but its carboxylate form exhibits also high affinity to HSA. The latter propertyexcludes this compound as a candidate to be a good anticancer drug.

Conclusions. Fluorescence anisotropy measurements show that the lactone forms of 1Si-CPT and 2Si-CPTexhibit a high affinity to membranes but only the carboxylate form of 2Si-CPT behaves in a desirable way inHSA solution i.e. it exhibits a low affinity to this protein. This means that 2Si-CPT could be an excellent candidatefor further in vivo pharmacological studies, and most probably for clinical trials in cancer chemotherapy.

Get Citation
About this article
Title

Fluorescence spectroscopy in a study of anticancer drugs: 7-tert-butyldimethylsilyl-camptothecin and 7-tert-butyldimethylsilyl-10-[4- (1-piperidino)-1-piperidino]-carbonyloxycamptothecin

Journal

Medical Research Journal

Issue

Vol 1, No 1 (2013)

Article type

Original article

Pages

23-30

Published online

2013-07-11

Page views

885

Article views/downloads

3908

Bibliographic record

Folia Medica Copernicana 2013;1(1):23-30.

Authors

Natalia Sørbotten
Stefan Kruszewski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl